PI11275 Ethyl (3R,4R)-4-[(tert-butoxycarbonyl)amino]-3-hydroxy-1-piperidinecarboxylate (CAS No.: 283160-20-3)

Ethyl (3R,4R)-4-[(tert-butoxycarbonyl)amino]-3-hydroxy-1-piperidinecarboxylate (CAS No.: 283160-20-3) Description

Ethyl (3R,4R)-4-[(tert-butoxycarbonyl)amino]-3-hydroxy-1-piperidinecarboxylate is a chiral intermediate employed in the synthesis of complex pharmaceutical compounds. The defined stereochemistry ensures controlled reaction pathways and minimises by-product formation. Presented in powder form, it facilitates precise dosing and uniform mixing during chemical transformations, thereby promoting reproducibility and efficiency in synthesis protocols.

Ethyl (3R,4R)-4-[(tert-butoxycarbonyl)amino]-3-hydroxy-1-piperidinecarboxylate (CAS No.: 283160-20-3) Applications

1.         Pharmaceutical Synthesis
   - Used as a chiral building block in active pharmaceutical ingredient production to achieve stereoselective reactions by leveraging its defined stereochemistry.

2.         Analytical Research
   - Applied in method development and process optimisation studies to refine reaction mechanisms by utilising its consistent analytical profile and reactivity characteristics.

Ethyl (3R,4R)-4-[(tert-butoxycarbonyl)amino]-3-hydroxy-1-piperidinecarboxylate (CAS No.: 283160-20-3) Packing

The compound is packaged in moisture-resistant, sealed containers with inert gas blanketing to minimise oxidation and contamination. Secondary protective wrapping further prevents particulate ingress during transit. Storage must occur in a cool, dry area away from direct light to maintain chemical integrity. Custom packaging options, including tamper-evident seals and specialised labelling, are available to accommodate specific handling requirements.

Additional Information

Pharmaceutical intermediates such as this compound play a crucial role in developing stereochemically precise active ingredients. They are pivotal for reaction predictability and efficiency, especially in multi-step syntheses where stringent purity requirements are necessary. Detailed analytical control, often via HPLC and NMR, underlines the importance of these intermediates in ensuring reproducible outcomes.

Chemical synthesis of chiral molecules necessitates rigorous quality assessments to achieve specific optical activity and minimise impurities. Understanding the reactivity and handling characteristics of such intermediates aids in optimising reaction conditions and scaling up production while maintaining consistency and compliance with regulatory standards.